Pre-clinical Research Based on Existing Repurposing Tools
The summary for the Pre-clinical Research Based on Existing Repurposing Tools grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pre-clinical Research Based on Existing Repurposing Tools: This Funding Opportunity Announcement (FOA) will support rigorous, pre-clinical studies that establish the rationale for a clinical trial, where the hypothesis originates from use of a published or publicly available method for identifying new indications for existing drugs or biologics (therapeutics). The goal of an individual project will be to explore the potential new use of an existing investigational, phase 2a-ready, or FDA-approved drug or licensed biologic; a pre-clinical study funded through this initiative will serve as a use case to demonstrate the utility of an independent crowdsourcing effort or of a computational algorithm to predict new uses of a drug or biologic. Applicants must clearly identify the published or publicly available method used to identify a novel therapeutic/indication pair or combination therapy, in addition to describing the pre-clinical studies that will serve as the use case. This use cases must have a scientifically supported rationale where objective, quantifiable effects of the therapy can be measured.
Federal Grant Title: | Pre-clinical Research Based on Existing Repurposing Tools |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-TR-16-001 |
Type of Funding: | Grant |
CFDA Numbers: | 93.350 |
CFDA Descriptions: | National Center for Advancing Translational Sciences |
Current Application Deadline: | Jan 13, 2016 |
Original Application Deadline: | Jan 13, 2016 |
Posted Date: | Oct 21, 2015 |
Creation Date: | Oct 21, 2015 |
Archive Date: | Feb 13, 2016 |
Total Program Funding: | $4,300,000 |
Maximum Federal Grant Award: | $250,000 |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Native American tribal organizations (other than Federally recognized tribal governments)
Special district governments
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Small businesses
For profit organizations other than small businesses
Public housing authorities/Indian housing authorities
Private institutions of higher education
State governments
County governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Additional Information on Eligibility
- Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-16-001.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) f...
- • Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- • Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Dis...
- • Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not...
- • Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science ...
- • Limited Competition: Revision Applications to Advance Evidence-Based Research Related to P...
- • A Pre-application for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for...
- • Limited Competition for NIH-Industry Pilot Program: Discovering New Therapeutic Uses for E...
- More Grants from the National Institutes of Health
- • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...
- • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...
- • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
- • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...
- • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...